Clinical Trials Logo

Post-Stroke Elbow Spasticity clinical trials

View clinical trials related to Post-Stroke Elbow Spasticity.

Filter by:
  • None
  • Page 1

NCT ID: NCT02358005 Not yet recruiting - Clinical trials for Post-Stroke Elbow Spasticity

Optimal Dose of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity

Start date: February 2015
Phase: Phase 4
Study type: Interventional

Recently, It is known that the efficacy of botulinum toxin type A (BTX-A) with extracorporeal shock wave therapy (ESWT) is greater than that of BTX-A with electrical stimulation in the management of post-stroke spasticity of the upper limb. However, it was not determined which dose of ESWT is optimal as a adjuvant therapy after BTX-A injection on the upper limb in patients with stroke. Therefore, the aim of this study is to evaluate the optimal dose of ESWT after botulinum toxin type A injection for post-stroke spasticity